| Date | Title | Description | |
|---|---|---|---|
| 29 Sep 2025 | On corporate transactions: mergers, acquisitions and others | ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) | Download |
| 29 Sep 2025 | On corporate transactions: mergers, acquisitions and others | The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) | Download |
| 24 Jul 2025 | On P&L | The Company releases the press release related to the first half of 2025 financial results | Download |
| 24 Jul 2025 | On P&L | The Company releases the first half 2025 financial results presentation | Download |
| 25 Mar 2025 | On business and financial situation | The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 15 Feb 2022 | On business and financial situation | ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone. | Download |
| 14 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022 | Download |
| 07 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022 | Download |
| 31 Jan 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 24 January 2022 and 28 January 2022 | Download |
| 24 Jan 2022 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 17 January 2022 and 21 January 2022 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 08 Nov 2016 | Información sobre resultados | ROVI releases the presentation related to the nine-month period ended 30 September 2016 results | Download |
| 08 Nov 2016 | Información sobre resultados (2) | ROVI releases the press release related to the nine-month period ended 30 September 2016 results | Download |
| 08 Nov 2016 | Otros sobre Gobierno Corporativo | The Company informs about the agreement of the Board of Directors with regards to the appointment of the Accounts Auditor | Download |
| 04 Oct 2016 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the third quarter of 2016 | Download |
| 01 Aug 2016 | Acuerdos estratégicos con terceros | ROVI announces the marketing agreement of Mysimba in Spain | Download |